{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:28Z","timestamp":1791340468640,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2102,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/jid.2009.314","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T09:54:26Z","timestamp":1254995666000},"page":"816-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases"],"prefix":"10.1016","volume":"130","author":[{"given":"Anne","family":"Pham-Ledard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Prochazkova-Carlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Laharanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Vergier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jouary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Merlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2009.314_bb0010","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2133.2009.09147.x","article-title":"Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders","volume":"161","author":"Benner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.314_bb0020","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood.V91.12.4668","article-title":"Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations","volume":"91","author":"Beylot-Barry","year":"1998","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.314_bb0030","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni1500","article-title":"The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4","volume":"8","author":"Brustle","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2009.314_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2005.10.002","article-title":"A suggested protocol for obtaining high-quality skin metaphases from primary cutaneous T-cell lymphoma","volume":"167","author":"Chevret","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/jid.2009.314_bb0040","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2006-12-064683","article-title":"The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children","volume":"110","author":"Clappier","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0045","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2009.314_bb0050","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0055","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.314_bb0065","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.molimm.2009.05.178","article-title":"TRAF1 is involved in the classical NF-[kappa]B activation and CD30-induced alternative activity in Hodgkin's lymphoma cells","volume":"46","author":"Guo","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1038\/jid.2009.314_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2133.2008.09002.x","article-title":"MUM1 expression does not differentiate primary cutaneous anaplastic large-cell lymphoma and lymphomatoid papulosis","volume":"160","author":"Hernandez-Machin","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.314_bb0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2008.070858","article-title":"CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells","volume":"172","author":"Hirsch","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2009.314_bb0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng1097-226","article-title":"Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma","volume":"17","author":"Iida","year":"1997","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2009.314_bb0085","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1158\/0008-5472.CAN-04-0366","article-title":"Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue","volume":"65","author":"Karenko","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2009.314_bb0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1365-2133.2008.08566.x","article-title":"MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"158","author":"Kempf","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2009.314_bb0095","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1158\/0008-5472.CAN-08-3221","article-title":"Inhibition of constitutively activated nuclear factor-{kappa}B Induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma","volume":"69","author":"Kiessling","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2009.314_bb0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0105","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/bioinformatics\/btl359","article-title":"VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles","volume":"22","author":"La Rosa","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1038\/jid.2009.314_bb0110","doi-asserted-by":"crossref","first-page":"W477","DOI":"10.1093\/nar\/gkl215","article-title":"CAPweb: a bioinformatics CGH array analysis platform","volume":"34","author":"Liva","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/jid.2009.314_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.it.2008.07.006","article-title":"Interferon regulatory factor 4 and 8 in B-cell development","volume":"29","author":"Lu","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1038\/jid.2009.314_bb0120","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/jid.2008.113","article-title":"Primary cutaneous T-cell lymphomas do not show specific NAV3 gene deletion or translocation","volume":"128","author":"Marty","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2009.314_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.leu.2403543","article-title":"Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in \u201cunmutated\u201d B-CLL","volume":"19","author":"Michaux","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.314_bb0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.275.5299.540","article-title":"Requirement for the transcription factor LSIRF\/IRF4 for mature B and T lymphocyte function","volume":"275","author":"Mittrucker","year":"1997","journal-title":"Science"},{"key":"10.1038\/jid.2009.314_bb0135","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0140","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.bjc.6603433","article-title":"Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q","volume":"95","author":"Orsetti","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1038\/jid.2009.314_bb0145","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/sj.leu.2405027","article-title":"The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma","volume":"22","author":"Remstein","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.314_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature07064","article-title":"IRF4 addiction in multiple myeloma","volume":"454","author":"Shaffer","year":"2008","journal-title":"Nature"},{"key":"10.1038\/jid.2009.314_bb0155","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-08-1845","article-title":"IRF4: Immunity. Malignancy! Therapy?","volume":"15","author":"Shaffer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2009.314_bb0160","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-{kappa}B canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0165","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1038\/jid.2009.314_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(01)00436-8","article-title":"Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma","volume":"129","author":"Tamura","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/jid.2009.314_bb0175","series-title":"Human Chromosomes. Principales and Techniques","author":"Verma","year":"1995"},{"key":"10.1038\/jid.2009.314_bb0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.humpath.2007.08.013","article-title":"The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders","volume":"39","author":"Wasco","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1038\/jid.2009.314_bb0185","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0190","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1074\/jbc.M608817200","article-title":"CD30 activates both the canonical and alternative NF-{kappa}B pathways in anaplastic large cell lymphoma cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2009.314_bb0195","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/sj.leu.2401563","article-title":"Detection of MUM1\/IRF4-IgH fusion in multiple myeloma","volume":"13","author":"Yoshida","year":"1999","journal-title":"Leukemia"},{"key":"10.1038\/jid.2009.314_bb0200","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/blood-2007-08-108654","article-title":"PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor","volume":"111","author":"Zhao","year":"2008","journal-title":"Blood"},{"key":"10.1038\/jid.2009.314_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"10.1038\/jid.2009.314_bb0210","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","article-title":"Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"25","author":"Zinzani","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15347485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15347485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:25:54Z","timestamp":1743960354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15347485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0022202X15347485"],"URL":"https:\/\/doi.org\/10.1038\/jid.2009.314","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2009.314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}